Evidence map›Paper›PMID 37653041›Full record

ArticleNature metabolism2023

Adipocytes reprogram cancer cell metabolism by diverting glucose towards glycerol-3-phosphate thereby promoting metastasis.

Abir Mukherjee, Divya Bezwada, Francesco Greco, Malu Zandbergen, Tong Shen, Chun-Yi Chiang, Medine Tasdemir, Johannes Fahrmann, Dmitry Grapov, Michael R La Frano and 8 more

Open access · greenAbstract read
In one paragraph

Article in Nature metabolism, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
12.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 54 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. TRMT6/TRMT61A-mediated tRNA mCellular & molecular biology letters · 2026
    Article
  12. Article
  13. Observational
  14. Review
  15. Article
  16. Article
  17. Review
  18. Targeting Hyperglycemic Bone Pre-Metastatic Niche for Breast Cancer Bone Metastasis Therapy.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  19. CHP1 promotes lipid droplet growth and regulates the localization of key enzymes for triacylglycerol synthesis.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 6 institutions in 2 countries.

Abir MukherjeeDepartment of Obstetrics and Gynecology/Section of Gynecologic Oncology-Center for Integrative Sciences, University of Chicago, Chicago, IL, USA.ORCID http://orcid.org/0000-0001-5234-0136
Divya BezwadaChildren's Medical Center Research Institute, University of Texas Southwestern Medical Center, Dallas, TX, USA.ORCID http://orcid.org/0000-0002-5434-2976
Francesco GrecoFondazione Pisana per la Scienza ONLUS, San Giuliano Terme, Italy.ORCID http://orcid.org/0000-0001-7059-528X
Malu ZandbergenDepartment of Obstetrics and Gynecology/Section of Gynecologic Oncology-Center for Integrative Sciences, University of Chicago, Chicago, IL, USA.
Tong ShenNIH West Coast Metabolomics Center, University of California, Davis, CA, USA.
Chun-Yi ChiangDepartment of Obstetrics and Gynecology/Section of Gynecologic Oncology-Center for Integrative Sciences, University of Chicago, Chicago, IL, USA.ORCID http://orcid.org/0009-0008-6983-0252
Medine TasdemirDepartment of Obstetrics and Gynecology/Section of Gynecologic Oncology-Center for Integrative Sciences, University of Chicago, Chicago, IL, USA.ORCID http://orcid.org/0000-0001-5137-7308
Johannes FahrmannDepartment of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Dmitry GrapovNIH West Coast Metabolomics Center, University of California, Davis, CA, USA.ORCID http://orcid.org/0000-0002-7204-3128
Michael R La FranoNIH West Coast Metabolomics Center, University of California, Davis, CA, USA.ORCID http://orcid.org/0000-0002-2269-1688
Hieu S VuChildren's Medical Center Research Institute, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Brandon FaubertDepartment of Medicine/Section of Hematology and Oncology, University of Chicago, Chicago, IL, USA.ORCID http://orcid.org/0000-0002-2886-886X
John W NewmanNIH West Coast Metabolomics Center, University of California, Davis, CA, USA.ORCID http://orcid.org/0000-0001-9632-6571
Liam A McDonnellInstitute of Life Sciences, Sant'Anna School of Advanced Studies, Pisa, Italy.ORCID http://orcid.org/0000-0003-0595-9491
Luigi NeziDepartment of Experimental Oncology, IRCCS European Institute of Oncology, Milano, Italy.ORCID http://orcid.org/0000-0002-4670-7656
Oliver FiehnNIH West Coast Metabolomics Center, University of California, Davis, CA, USA.ORCID http://orcid.org/0000-0002-6261-8928
Ralph J DeBerardinisChildren's Medical Center Research Institute, University of Texas Southwestern Medical Center, Dallas, TX, USA.ORCID http://orcid.org/0000-0002-2705-7432
Ernst LengyelDepartment of Obstetrics and Gynecology/Section of Gynecologic Oncology-Center for Integrative Sciences, University of Chicago, Chicago, IL, USA. elengyel@uchicago.edu.ORCID http://orcid.org/0000-0001-8624-1507
University of Chicago · USUniversity of California, Davis · USChildren's Medical Center · USScuola Superiore Sant'Anna · ITEuropean Institute of Oncology · ITThe University of Texas MD Anderson Cancer Center · US

Funding

Metabolic Regulators of Tumor Growth and ProgressionR35CA220449 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI RALPH J DEBERARDINIS · 2017 to 2026
$9.4M
UT Southwestern NORCP30DK127984 · NIDDK · UT SOUTHWESTERN MEDICAL CENTER · PI Shawn C Burgess · 2022 to 2026
$7.4M
Metabolic reprogramming of the tumor microenvironment and therapy resistanceR35CA264619 · NCI · UNIVERSITY OF CHICAGO · PI Ernst Lengyel · 2021 to 2026
$5.2M
Metabolic changes in ovarian cancer cells initiated by metastasis to adipose tissR01CA169604 · NCI · UNIVERSITY OF CHICAGO · PI LENGYEL, ERNST · 2013 to 2017
$1.7M
Dissecting Fatty Acid Metabolism in Clear Cell Renal Cell Carcinoma (ccRCC)F31CA239330 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI BEZWADA, DIVYA · 2019 to 2021
$103k
NCI NIH HHS F31 CA239330NCI NIH HHS R01 CA169604NCI NIH HHS R35 CA220449NCI NIH HHS R35 CA264619NIDDK NIH HHS P30 DK127984
6 · The paper itself

Abstract

In the tumor microenvironment, adipocytes function as an alternate fuel source for cancer cells. However, whether adipocytes influence macromolecular biosynthesis in cancer cells is unknown. Here we systematically characterized the bidirectional interaction between primary human adipocytes and ovarian cancer (OvCa) cells using multi-platform metabolomics, imaging mass spectrometry, isotope tracing and gene expression analysis. We report that, in OvCa cells co-cultured with adipocytes and in metastatic tumors, a part of the glucose from glycolysis is utilized for the biosynthesis of glycerol-3-phosphate (G3P). Normoxic HIF1α protein regulates the altered flow of glucose-derived carbons in cancer cells, resulting in increased glycerophospholipids and triacylglycerol synthesis. The knockdown of HIF1α or G3P acyltransferase 3 (a regulatory enzyme of glycerophospholipid synthesis) reduced metastasis in xenograft models of OvCa. In summary, we show that, in an adipose-rich tumor microenvironment, cancer cells generate G3P as a precursor for critical membrane and signaling components, thereby promoting metastasis. Targeting biosynthetic processes specific to adipose-rich tumor microenvironments might be an effective strategy against metastasis.

Indexed as

GlycerolOvarian NeoplasmsAdipocytesFemaleGlucoseGlycerophosphatesHumansPhosphatesTumor Microenvironmentalpha-glycerophosphoric acidGlucoseGlycerolGlycerophosphatesPhosphates

Identifiers

PMID37653041
PMCPMC12175003
OpenAlexW4386309657

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.